Shanghai Hepu Pharmaceutical Co., Ltd.
PrivateLast Round
Early Funding
Jul 4, 2022
Est. Valuation
$12.3M
Total Funding Raised
$31.59M
Company Overview
Shanghai Hepu Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was an Early Funding round in July 2022.
Shanghai Hepu Pharmaceutical Co., Ltd. is a biotechnology company that researches and develops original new drugs for the treatment of hepatitis, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Hepu Pharmaceutical Co., Ltd. Comparables
Compare Shanghai Hepu Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Huahui Health Ltd. | 83% | |
| Suzhou HepaThera Biotech Co., Ltd. | 80% | |
| Drug Farm | 77% |
For institutional investors. Book with your work email.
Shanghai Hepu Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 4, 2022 | ||||
| Seed | Nov 1, 2013 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2022
$15M raised in early funding.
- Nov 1, 2013
$13M raised from Shanghai Hepu Pharmaceutical Co., Ltd.
For institutional investors. Book with your work email.
Shanghai Hepu Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Hepu Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Hepu Pharmaceutical Co., Ltd. a public or private company?
Shanghai Hepu Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Shanghai Hepu Pharmaceutical Co., Ltd.?
Shanghai Hepu Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Hepu Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Hepu Pharmaceutical Co., Ltd. worth (valuation)?
Shanghai Hepu Pharmaceutical Co., Ltd.'s valuation is estimated at $12.3M based on funding round data.
Can I buy Shanghai Hepu Pharmaceutical Co., Ltd. stock?
Shanghai Hepu Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Hepu Pharmaceutical Co., Ltd.'s last funding round?
Shanghai Hepu Pharmaceutical Co., Ltd.'s most recent funding round was Early Funding on July 4, 2022.
Who are the main investors in Shanghai Hepu Pharmaceutical Co., Ltd.?
Investor information for Shanghai Hepu Pharmaceutical Co., Ltd. is not publicly disclosed.
Will Shanghai Hepu Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Hepu Pharmaceutical Co., Ltd..
How can I track Shanghai Hepu Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Hepu Pharmaceutical Co., Ltd.'s shares on secondary markets.